A new organization of endocrinologists, focused on reducing complications from diabetes, has been formed. The Council for the Advancement of Diabetes Research and Education (CADRE) is underwritten by joint unrestricted educational grants from Aventis Pharmaceuticals Inc. and Pfizer Inc. Both firms offer diabetes therapies.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments